GM-CSF can promote cancer progression by inducing pro-tumorigenic immune cells such as myeloid-derived suppressor cells (MDSCs), tumor-associated macrophages (TAMs), and Treg cells [6,28]. This evidence concerns the gene CSF2 and cancer.